Study
Hibiscus and Myrrh Supplements Reduce UTIs in Women with Recurring Infections
A combination of hibiscus extract, vegetable proteases, and myrrh helped prevent urinary tract infections (UTIs) in nearly half of women with recurring infections.
Summary
In plain language
Researchers studied the effects of a supplement containing hibiscus extract, vegetable proteases, and myrrh on women who frequently experience urinary tract infections (UTIs). The study found that nearly half of the participants reported no symptomatic UTI episodes after using the supplement, and many others experienced fewer infections. This is important because recurrent UTIs can significantly affect one's quality of life. For seniors, this study suggests a potential alternative to antibiotics, which can lead to drug resistance and other side effects. It's always a good idea to discuss any new supplement with your healthcare provider.
Details
Use the full description to understand the study design, methods, and the limits of the findings.
This study involved women with a history of recurring urinary tract infections. Participants took a specific supplement combination twice daily for one week, followed by once daily for ten days each month over six months.
Nearly 49% of participants did not experience any symptomatic UTIs, while 35.3% had fewer than two episodes during the study period.
The quality of life improved significantly for 74.5% of participants after three months and 84.3% after six months.
Although promising, the study was not randomized, and participants were already motivated to prevent UTIs, which may have influenced results.
If you're considering this supplement, discuss it with your healthcare provider to ensure it's right for you.
Full Study
Open the original publication for the complete methods, outcomes, and source material.
Hibiscus and Myrrh Supplements Reduce UTIs in Women with Recurring Infections
Published September 2026
Opens at the publisher · external site · may require institutional access
Research Quality Score
Scored September 29, 2026 using rubric mq-1.8_2026-07-06.
Assessment
The study is a prospective phase II trial, providing moderate evidence quality. However, lack of randomization and blinding limits bias control. Statistical methods are robust, but transparency is limited by the absence of a pre-registered protocol. No conflicts were detected, but the lack of a disclosure statement affects transparency. The study's relevance to seniors is partial, and journal quality is unassessed.
Category Breakdown
| Category | Score | Rating |
|---|---|---|
| Study design | 6.7/10 | |
| Bias control | 3.3/10 | |
| Statistical methods | 10.0/10 | |
| Reporting completeness | 5.0/10 | |
| Conflicts & funding | 5.0/10 | |
| Replication | 0.0/10 | |
| Relevance to chosen population | 5.0/10 | |
| Journal Reliability | 5.0/10 |
Additional Notes
The study evaluates the efficacy of a combination of hibiscus extract, vegetable proteases, and Commiphora myrrha in preventing symptomatic UTIs in women with recurrent infections, showing a reduction in UTI episodes and improvement in quality of life.
Assessed on the study's full text across 8 quality dimensions; conflict-of-interest disclosures were checked.
Conditions This Research Covers
These condition pages help connect the paper back to the real-world health concerns it addresses.
Take the next step
Build a personalized plan using research-backed studies, conditions, and treatments.